A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, blood platelet disease, coagulation protein disease, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, von Willebrand disease (hereditary or acquired)	Recruiting	Phase 2	2026-06-11		NCT07640893

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai RAAS Blood Products Co., Ltd.	3

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Henan Provincial People's Hospital	Zhengzhou	China	21
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences	Tianjin	China	9
Jinan Central Hospital	Jinan	China	15
North China University of Science and Technology Affiliated Hospital	Tangshan	China	4
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	24
The First Affiliated Hospital of Soochow University	Suzhou	China	28
The First Affiliated Hospital of University of Science and Technology of China	Hefei	China	5
The Second Hospital of Shanxi Medical University	Taiyuan	China	4
Xiangya Hospital of Central South University	Changsha	China	20